PharmaPrint Stock Sale

PharmaPrint Inc. plans to sell 2.25 million shares of common stock to the public, according to a registration statement filed Wednesday with the Securities and Exchange Commission.

The price will be determined by the stock’s trading price at the time the shares are offered, the company said.

PharmaPrint develops pharmaceutical-grade dietary supplements and pharmaceuticals from botanical sources.